Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Chronic scalp lesions with crusts and pus indicate Erosive Pustular Dermatosis, which is confirmed by biopsy and effectively treated with strong topical steroids.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

DMG-Na may improve blood flow and help hair growth without side effects.

Diphencyprone helped most patients with alopecia areata regrow some hair.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

The chitosan/PDRN polyplex improved wound healing in diabetic rats.

Dermatopathia pigmentosa reticularis causes skin discoloration, hair loss, and nail problems.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

DLP bioprinting shows promise for medical uses, but needs more material options and strength improvements.

DCPA is a chronic skin condition affecting the lower limbs, mainly in men, with unclear causes and treatments that often don't work well.

Topical dapsone gel reduced flare-ups in folliculitis decalvans without side effects.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

A long-term pubic rash was finally diagnosed as white piedra and cured with ketoconazole.

PDCD4 is important for controlling skin cell growth and healing.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Dissolving microneedles with finasteride improve drug delivery for hair loss treatment.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Nano-sized lipid particles increase dexamethasone's skin penetration and create a reservoir in the skin layers.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Proper cleansing can resolve dermatosis neglecta, which may indicate underlying psychiatric issues.

Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.